To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) representatives of the pharmaceutical industry, (b) the NHS, (c) Cabinet colleagues and (d) other stakeholders on indication-specific pricing of medications use
My Rt Hon. Friend, the Secretary of State for Health and Social Care has not held any meetings specifically on the topic of indication-specific pricing of medications used in the treatment of more than one form of cancer.
Cancer: Medical Treatments